COVID-19大流行是否延迟了局部乳腺癌患者的治疗? 一个多中心的研究研究
Ke Zhou1, Marie Robert2, Valérie Seegers3
1Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.
PloS one
|May 31, 2024
概括
COVID-19大流行并没有直接影响局部乳腺癌 (BC) 患者的治疗延迟. 其他因素,而不是大流行,与治疗和手术延迟更长有关.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,癌症治疗的延迟可能会增加.
- 很少有研究量化了因疫情而导致癌症治疗延迟的患者水平.
研究的目的:
- 为了评估COVID-19大流行期间新诊断的局部乳腺癌 (BC) 患者的治疗和手术延迟的变化.
主要方法:
- 利用了来自法国PAPESCO-19多中心队列研究的数据.
- 从诊断到第一次治疗 (新辅助化疗或手术) 的测量延迟.
- 评估了使用综合指数的流行病严重程度和封锁限制的流行病暴露;采用了通用线性模型.
主要成果:
- 在第一次封锁之前和之后诊断的患者中,初次治疗的中位延迟为42天.
- 较高的综合流行病指数在调整后对治疗时间产生了小而无意义的影响.
- 与COVID-19大流行无关的因素与更长的治疗延迟有关.
结论:
- 在局部乳腺癌 (BC) 患者中,没有观察到COVID-19大流行对实际治疗延迟的直接影响.
- 局部BC的治疗延迟主要受到大流行以外的其他因素的影响.
更多相关视频
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.6K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
